Your browser doesn't support javascript.
loading
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.
Bitzer, Michael; Horger, Marius; Giannini, Edoardo G; Ganten, Tom M; Wörns, Marcus A; Siveke, Jens T; Dollinger, Matthias M; Gerken, Guido; Scheulen, Max E; Wege, Henning; Zagonel, Vittorina; Cillo, Umberto; Trevisani, Franco; Santoro, Armando; Montesarchio, Vincenzo; Malek, Nisar P; Holzapfel, Julia; Herz, Thomas; Ammendola, Astrid S; Pegoraro, Stefano; Hauns, Bernhard; Mais, Anna; Lauer, Ulrich M; Henning, Stefan W; Hentsch, Bernd.
Affiliation
  • Bitzer M; Department of Internal Medicine I, Eberhard Karls University, Tuebingen, Germany. Electronic address: michael.bitzer@uni-tuebingen.de.
  • Horger M; Department of Diagnostic & Interventional Radiology, Eberhard Karls University, Tuebingen, Germany.
  • Giannini EG; Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
  • Ganten TM; Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany.
  • Wörns MA; First Department of Medicine, Johannes Gutenberg-University, Mainz, Germany.
  • Siveke JT; Second Department of Internal Medicine, Technical University, Munich, Germany.
  • Dollinger MM; Internal Medicine I, University Ulm, Ulm, Germany.
  • Gerken G; Center for Internal Medicine, University Clinic, Essen, Germany.
  • Scheulen ME; Department of Medical Oncology, West German Cancer Center, Essen, Germany.
  • Wege H; University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Zagonel V; Medical Oncology Unit 1, Istituto Oncologico Veneto, IRCCS, Padova, Italy.
  • Cillo U; Hepatobiliary Surgery and Liver Transplant Unit, Azienda Università di Padova, Padova, Italy.
  • Trevisani F; University of Bologna, Bologna, Italy.
  • Santoro A; Department of Oncology, Humanitas Cancer Center, Rozzano, Italy.
  • Montesarchio V; UO Oncologia Ospedale Cotugno Napoli, Napoli, Italy.
  • Malek NP; Department of Internal Medicine I, Eberhard Karls University, Tuebingen, Germany.
  • Holzapfel J; 4SC AG, Planegg-Martinsried, Germany.
  • Herz T; 4SC AG, Planegg-Martinsried, Germany.
  • Ammendola AS; 4SC AG, Planegg-Martinsried, Germany.
  • Pegoraro S; 4SC AG, Planegg-Martinsried, Germany.
  • Hauns B; 4SC AG, Planegg-Martinsried, Germany.
  • Mais A; 4SC AG, Planegg-Martinsried, Germany.
  • Lauer UM; Department of Internal Medicine I, Eberhard Karls University, Tuebingen, Germany.
  • Henning SW; 4SC AG, Planegg-Martinsried, Germany.
  • Hentsch B; 4SC AG, Planegg-Martinsried, Germany.
J Hepatol ; 65(2): 280-8, 2016 08.
Article in En | MEDLINE | ID: mdl-26952006
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2016 Document type: Article Country of publication: Netherlands